Michael Schmidt
Stock Analyst at Guggenheim
(3.89)
# 524
Out of 4,883 analysts
113
Total ratings
57.47%
Success rate
7.57%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Michael Schmidt
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RVMD Revolution Medicines | Reiterates: Buy | $80 | $37.19 | +115.14% | 4 | Jun 25, 2025 | |
| AVBP ArriVent BioPharma | Reiterates: Buy | $45 | $21.11 | +113.17% | 2 | Jun 24, 2025 | |
| ADCT ADC Therapeutics | Maintains: Buy | $7 → $10 | $2.80 | +257.14% | 5 | Jun 13, 2025 | |
| URGN UroGen Pharma | Maintains: Buy | $40 → $15 | $12.96 | +15.74% | 1 | May 23, 2025 | |
| MRSN Mersana Therapeutics | Reiterates: Buy | $5 | $0.28 | +1,687.63% | 3 | May 16, 2025 | |
| KYMR Kymera Therapeutics | Reiterates: Buy | $52 | $44.53 | +16.78% | 1 | May 12, 2025 | |
| SWTX SpringWorks Therapeutics | Reiterates: Neutral | $47 | $46.99 | +0.02% | 3 | May 12, 2025 | |
| CMPX Compass Therapeutics | Maintains: Buy | $12 → $10 | $2.62 | +281.68% | 4 | May 9, 2025 | |
| ONC BeOne Medicines | Maintains: Buy | $348 → $350 | $243.84 | +43.54% | 3 | May 8, 2025 | |
| RLAY Relay Therapeutics | Maintains: Buy | $30 → $10 | $3.60 | +177.78% | 1 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $32 | $9.00 | +255.56% | 3 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $16 | $7.90 | +102.53% | 5 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $4.73 | +69.13% | 2 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $109 | $53.33 | +104.39% | 5 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $1.75 | $0.24 | +621.95% | 3 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $14 | $4.85 | +188.66% | 3 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $25 | $8.63 | +189.69% | 2 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $92 | $68.17 | +34.96% | 5 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $35.91 | - | 1 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $10.65 | - | 5 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $42 | $44.30 | -5.19% | 10 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $0.56 | - | 1 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $128.20 | - | 2 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $2.78 | +619.42% | 1 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $1.24 | +545.16% | 3 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $32.75 | - | 3 | Oct 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.91 | - | 2 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.59 | - | 2 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.20 | - | 1 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $34 | $8.30 | +309.64% | 4 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $20 | $0.61 | +3,157.33% | 3 | Jun 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $20.44 | - | 2 | Jan 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $1.45 | +1,624.14% | 1 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $4.73 | +534.92% | 1 | Jul 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $26 | $3.26 | +697.55% | 1 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.65 | - | 2 | Apr 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $80 | $35.35 | +126.31% | 5 | Feb 15, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $6.96 | - | 6 | Jan 17, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $4 → $5.5 | $3.19 | +72.41% | 2 | Nov 7, 2017 |
Revolution Medicines
Jun 25, 2025
Reiterates: Buy
Price Target: $80
Current: $37.19
Upside: +115.14%
ArriVent BioPharma
Jun 24, 2025
Reiterates: Buy
Price Target: $45
Current: $21.11
Upside: +113.17%
ADC Therapeutics
Jun 13, 2025
Maintains: Buy
Price Target: $7 → $10
Current: $2.80
Upside: +257.14%
UroGen Pharma
May 23, 2025
Maintains: Buy
Price Target: $40 → $15
Current: $12.96
Upside: +15.74%
Mersana Therapeutics
May 16, 2025
Reiterates: Buy
Price Target: $5
Current: $0.28
Upside: +1,687.63%
Kymera Therapeutics
May 12, 2025
Reiterates: Buy
Price Target: $52
Current: $44.53
Upside: +16.78%
SpringWorks Therapeutics
May 12, 2025
Reiterates: Neutral
Price Target: $47
Current: $46.99
Upside: +0.02%
Compass Therapeutics
May 9, 2025
Maintains: Buy
Price Target: $12 → $10
Current: $2.62
Upside: +281.68%
BeOne Medicines
May 8, 2025
Maintains: Buy
Price Target: $348 → $350
Current: $243.84
Upside: +43.54%
Relay Therapeutics
May 7, 2025
Maintains: Buy
Price Target: $30 → $10
Current: $3.60
Upside: +177.78%
May 6, 2025
Reiterates: Buy
Price Target: $32
Current: $9.00
Upside: +255.56%
May 2, 2025
Maintains: Buy
Price Target: $32 → $16
Current: $7.90
Upside: +102.53%
Apr 4, 2025
Maintains: Buy
Price Target: $12 → $8
Current: $4.73
Upside: +69.13%
Mar 28, 2025
Reiterates: Buy
Price Target: $109
Current: $53.33
Upside: +104.39%
Mar 26, 2025
Maintains: Buy
Price Target: $3 → $1.75
Current: $0.24
Upside: +621.95%
Mar 24, 2025
Maintains: Buy
Price Target: $13 → $14
Current: $4.85
Upside: +188.66%
Mar 20, 2025
Maintains: Buy
Price Target: $35 → $25
Current: $8.63
Upside: +189.69%
Mar 18, 2025
Downgrades: Neutral
Price Target: $92
Current: $68.17
Upside: +34.96%
Mar 12, 2025
Reiterates: Neutral
Price Target: n/a
Current: $35.91
Upside: -
Feb 26, 2025
Reiterates: Buy
Price Target: n/a
Current: $10.65
Upside: -
Feb 12, 2025
Reiterates: Buy
Price Target: $42
Current: $44.30
Upside: -5.19%
Jan 22, 2025
Reiterates: Buy
Price Target: n/a
Current: $0.56
Upside: -
Dec 11, 2024
Reiterates: Buy
Price Target: n/a
Current: $128.20
Upside: -
Dec 6, 2024
Reiterates: Buy
Price Target: $20
Current: $2.78
Upside: +619.42%
Nov 15, 2024
Maintains: Buy
Price Target: $12 → $8
Current: $1.24
Upside: +545.16%
Oct 7, 2024
Downgrades: Neutral
Price Target: n/a
Current: $32.75
Upside: -
May 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $5.91
Upside: -
Mar 14, 2024
Downgrades: Neutral
Price Target: n/a
Current: $3.59
Upside: -
Jan 5, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.20
Upside: -
Nov 8, 2023
Maintains: Buy
Price Target: $40 → $34
Current: $8.30
Upside: +309.64%
Jun 27, 2023
Downgrades: Neutral
Price Target: $20
Current: $0.61
Upside: +3,157.33%
Jan 3, 2022
Downgrades: Neutral
Price Target: n/a
Current: $20.44
Upside: -
Aug 10, 2021
Initiates: Buy
Price Target: $25
Current: $1.45
Upside: +1,624.14%
Jul 19, 2021
Initiates: Buy
Price Target: $30
Current: $4.73
Upside: +534.92%
May 18, 2021
Initiates: Buy
Price Target: $26
Current: $3.26
Upside: +697.55%
Apr 28, 2021
Downgrades: Neutral
Price Target: n/a
Current: $1.65
Upside: -
Feb 15, 2019
Upgrades: Outperform
Price Target: $80
Current: $35.35
Upside: +126.31%
Jan 17, 2019
Initiates: Outperform
Price Target: n/a
Current: $6.96
Upside: -
Nov 7, 2017
Maintains: Market Perform
Price Target: $4 → $5.5
Current: $3.19
Upside: +72.41%